MOESM1 of Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan

Abstract

Additional file 1: Table S1. International Classification of Disease (9th edition) Clinical Modification (ICD 9-CM) codes used to define the co-morbidities and clinical outcome in the study cohort